The role of iron in type 2 diabetes in humans

SN Rajpathak, JP Crandall, J Wylie-Rosett… - … et Biophysica Acta (BBA …, 2009 - Elsevier
… Although the frequency of the alleles (S, M and L) did not differ significantly between cases
and controls in this study, the frequency of the SM genotype was higher and that of the SS …

[PDF][PDF] Incidence and prevalence of diabetes mellitus in the Americas

A Barceló, S Rajpathak - Revista Panamericana de Salud …, 2001 - SciELO Public Health
Objective. To present the incidence and prevalence of diabetes mellitus in the Americas as
found through a thorough review of published information on the subject. Methods. Data …

The role of insulin‐like growth factor‐I and its binding proteins in glucose homeostasis and type 2 diabetes

SN Rajpathak, MJ Gunter… - Diabetes/metabolism …, 2009 - Wiley Online Library
This review addresses the possible role of the insulin‐like growth factor (IGF)‐axis in normal
glucose homoeostasis and in the etiopathogenesis of type 2 diabetes. IGF‐I, a peptide …

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes …

…, K Reynolds, AP McGinn, S Rajpathak… - Archives of internal …, 2008 - jamanetwork.com
Background The prevalence and correlates of obese individuals who are resistant to the
development of the adiposity-associated cardiometabolic abnormalities and normal-weight …

[PDF][PDF] The cost of diabetes in Latin America and the Caribbean

…, C Aedo, S Rajpathak, S Robles - Bulletin of the world …, 2003 - SciELO Public Health
… For all the calculations in this study, we used Amos et al.’s prevalence estimates for 2000
(2). We used the distribution by age from a recent diabetes survey in Bolivia to break down the …

Statin therapy and risk of developing type 2 diabetes: a meta-analysis

SN Rajpathak, DJ Kumbhani, J Crandall… - Diabetes …, 2009 - Am Diabetes Assoc
OBJECTIVE Although statin therapy reduces cardiovascular risk, its relationship with the
development of diabetes is controversial. The first study (West of Scotland Coronary Prevention …

Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus

…, X Li, SS Engel, LM Moore, S Rajpathak - … medical research and …, 2016 - Taylor & Francis
Objective: Patients with type 2 diabetes (T2DM) often have multiple comorbidities which
may impact the selection of antihyperglycemic therapies. The purpose of this study was to …

[HTML][HTML] Changes in caffeine intake and long-term weight change in men and women

E Lopez-Garcia, RM van Dam, S Rajpathak… - The American journal of …, 2006 - Elsevier
… Caffeine is often combined with ephedrine because it boosts ephedrine’s thermogenic
effect ( 8 , 29 ). However, dietary supplements containing ephedra alkaloids have also been …

Sulphonylureas and risk of cardiovascular disease: systematic review and meta‐analysis

…, RW Allen, SS Engel, SN Rajpathak - Diabetic …, 2013 - Wiley Online Library
Aims Sulphonylurea use has been linked with increased cardiovascular disease risk; however,
previous studies have been inconsistent. Type 2 diabetes independently increases risk …

Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta‐analysis

…, SS Engel, SN Rajpathak - Diabetes, Obesity and …, 2014 - Wiley Online Library
… Weighted mean differences ( WMD s) for changes from baseline and relative risks ( RR s)
[with 95% confidence intervals ( CIs )] were calculated using random‐effects model. …